Nephros, Inc. (NEPH) earnings
NEPH earnings moved a median of -1.48% by the close. Quarterly and annual NEPH reports and results, each read against the price at its own news timestamp. Back to the NEPH overview →
20 measured NEPH earnings events.
Where these NEPH earnings landedvs 20 measured NEPH earnings reactions
| Middle 50% of NEPH earnings reactions | -2.33% to +1.06% |
|---|---|
| Median reaction (to close) | -1.48% |
| Measured reactions | 20 |
Point-in-time · zero look-ahead
Half of the 20 NEPH earnings events with a measured close landed between -2.33% and +1.06%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Nephros Schedules Second Quarter 2026 Financial Results Conference Call | Press release | — | +1.13% | |
| Form 10-Q NEPHROS INC For: Mar 31 | SEC filing · Form 10-Q | -2.91% | +13.92% | |
| Form 10-K/A NEPHROS INC For: Dec 31 | SEC filing · Form 10-K | — | -1.58% | |
| Nephros Schedules First Quarter 2026 Financial Results Conference Call | Press release | — | -1.58% | |
| Form 10-K NEPHROS INC For: Dec 31 | SEC filing · Form 10-K | -0.82% | -3.85% | |
| Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call | Press release | +0.26% | +1.04% | |
| Form 10-Q NEPHROS INC For: Sep 30 | SEC filing · Form 10-Q | -2.55% | -13.21% | |
| ¬Nephros Schedules Third Quarter 2025 Financial Results Conference Call | Press release | +0.00% | +1.24% | |
| Form 10-Q NEPHROS INC For: Jun 30 | SEC filing · Form 10-Q | -2.65% | +14.71% | |
| Nephros Schedules Second Quarter 2025 Financial Results Conference Call | Press release | +0.00% | -1.72% | |
| Form 10-Q NEPHROS INC For: Mar 31 | SEC filing · Form 10-Q | — | -1.37% | |
| Form 10-K NEPHROS INC For: Dec 31 | SEC filing · Form 10-K | — | +0.66% | |
| Form 10-Q NEPHROS INC For: Sep 30 | SEC filing · Form 10-Q | — | +0.65% | |
| Nephros Schedules Third Quarter 2024 Financial Results Conference Call | Press release | — | -2.03% | |
| Form 10-Q NEPHROS INC For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.00% | |
| Nephros Schedules Second Quarter 2024 Financial Results Conference Call | Press release | — | +5.66% | |
| Form 10-Q NEPHROS INC For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -3.23% | |
| Form 10-K NEPHROS INC For: Dec 31 | SEC filing · Form 10-K | +0.00% | +0.96% | |
| Form 10-Q NEPHROS INC For: Sep 30 | SEC filing · Form 10-Q | — | -6.46% | |
| Nephros Schedules Third Quarter 2023 Financial Results Conference Call | Press release | +0.00% | -7.40% |
Keep exploring
More NEPH: analyst actions → · SEC filings → · NEPH overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Cannabis Sativa, Inc. (CBDS) | 114 | 0.00% | 35% |
| GLOBEIMMUNE INC (GBIM) | 113 | 0.00% | 38% |
| Compugen Ltd. - Ordinary Shares (CGEN) | 112 | -0.45% | 39% |
| PetIQ, Inc. - Class A (PETQ) | 112 | 0.00% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.